503315-75-1Relevant articles and documents
SULFONAMIDE COMPOUNDS TARGETING CD73 AND ADENOSINE RECEPTORS
-
Page/Page column 46-47, (2021/06/04)
The present invention relates to bispecific compound of formula (I) as dual inhibitors of CD73 and adenosine receptors. The present invention also relates to pharmaceutical compositions comprising said compounds or a pharmaceutically acceptable salt or a stereoisomer or a prodrug thereof and use of such compounds in the treatment of diseases mediated by CD73 and/or adenosine receptors, particularly A2aR or A2bR.